Click:
The Last Update Time:--
Personal Homepage
- Special Researcher
- Name (Pinyin):wangyi
- E-Mail:c3d5697224e83f231d74d526ceb2ff6a4f844f8eeaa6da7e75fb7ac7db009de59df1930c84410eb6fe2bfa386dd506c1f8b76b8e9c4273c544066d26f26212f072307726a5cf573d04371073f90da7b82e35277a2bab0d7182378c3e747a9147c254d718705fc3ce5a919966f48c0ad1281e40b0c657046f9a119d4d5fcabd8d
- Degree:Dr
- Professional Title:Special Researcher
- Teacher College:Life Sciences
3) Yunjia Li#, Yiqing Shen#, Hao Chen#, Lin Xue, Mei Huang, Haiming Wei, Jing Jin*, Yi Wang*. A heparanase-specific LYTAC degrader reinforces natural killer cell cytotoxicity within the tumor microenvironment. Cell Reports Physical Science, 2024, 5 (12).
Release time:2025-06-12 Hits:
Pre One:2) Yunjia Li#, Lin Bai#, Hao Liang#, Peidong Yan#, Hao Chen#, Zhuoxian Cao#, Yiqing Shen, Zhongyv Wang, Mei Huang, Bin He, Quan Hao, Yide Mei, Haiming Wei, Chen Ding*, Jing Jin*, Yi Wang*. A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy. Molecular Therapy, 2025; 33(4):1566-1583.
Next One:4) Jing Jin#,* Lin Bai#, Dongyao Wang#, Wei Ding, Zhuoxian Cao, Peidong Yan, Yunjia Li, Lulu Xi, Yuxing Wang, Xiaohu Zheng, Haiming Wei, Chen Ding*, Yi Wang*. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Reports, 2023, 24 (5), e56052.